FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...
Two small-cap biotech names made serious noise today. Xenon Pharmaceuticals (XENE) is trading at $62.76, up 49.6% today, while Relmada Therapeutics (RLMD) sits at $7.17, also up 61.1% Both moves were ...
StudyFinds on MSN
For most older cancer patients, feeling well beats living longer. The healthcare system disagrees
In A Nutshell A new study found that nearly 72 percent of older adults with advanced cancer prioritized quality of life over survival, while only about 1 in 12 said living longer was their top ...
Inquirer.net on MSN
High HPV awareness, but barriers stall PH vaccination
MANILA, Philippines—Cervical cancer is one of the few cancers that can largely be prevented. Yet in the Philippines, thousands of women still die from it every year. Official nationwide health data ...
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced an update on the building momentum in the Company's launch of FDA-approved ZEVASKYN (prademagene ...
Data show that sentinel lymph node biopsy is becoming less routine for older women with breast early stage HR-positive, HER2-negative breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results